Although c-kit+ CPCs cannot differentiate into cardiomyocytes [43,44,45,46], transplantation of c-kit+ CPCs has been reproducibly shown to be beneficial in both preclinical and clinical studies for heart disease treatment [42,47,48,49,50]. This evidence concerns the gene KIT and heart disorder.